We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 171 start-ups with an aggregate funding of $5.8b. The average funding per company in this subset is $84.6m.
Last update to the database: Feb 18, 2025. See changelog.
A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer.
5
Funding Rounds
$76.5m
Money raised
Senti Biosciences is a synthetic biology company.
2
Funding Rounds
$158.0m
Money raised
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity.
1
Funding Rounds
$225.0m
Money raised
Orig3n is a biotechnology company developing personalized regenerative medicine treatments based on patient genetic profiles.
5
Funding Rounds
$111.8m
Money raised
Kuur Therapeutics focuses on the development of CAR-NKT cell therapies platform for applications in cancer treatment.
6
Funding Rounds
$190.5m
Money raised
Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products.
8
Funding Rounds
$117.5m
Money raised
Promethera Biosciences is a biotechnology company developing regenerative medicine treatments for liver diseases.
5
Funding Rounds
$103.1m
Money raised
ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes.
16
Funding Rounds
$328.8m
Money raised
A biotechnology company founded in 2015 which operates as a subsidiary of Gilead Sciences and Kite Pharma. The company developed a platform for custom cell engineering called synNotch to be used for anticancer therapies. Their system can also be used to develop cell-based therapies for autoimmune and degenerative disorders.
1
Funding Rounds
$34.4m
Money raised
A biopharmaceutical company developing therapeutics to attack cancer stem cells.
2
Funding Rounds
$13.8m
Money raised
EpiBone is a biotechnology startup company developing bone reconstruction solutions using stem cells. Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig founded EpiBone in 2013 and the company is headquartered in New York City, New York.
1
Funding Rounds
A biotechnology company using genetic editing technologies to develop therapies for the treatment of cancer and genetic diseases.
9
Funding Rounds
$262.0m
Money raised
Develops novel cell and gene therapies with pharmacologic operating systems.
2
Funding Rounds
$164.5m
Money raised
3T Biosciences is a biotechnology company developing immunotherapies.
3
Funding Rounds
$52.0m
Money raised
Biological micro-pancreas for insulin-dependent diabetics company
4
Funding Rounds
$5.1m
Money raised
Bit.bio is a biotechnology company that aims to operate within human cells through means of coding and biology.
3
Funding Rounds
$183.9m
Money raised
Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.
5
Funding Rounds
$425.0m
Money raised
Encellin is a biotechnology company developing diabetes therapeutics using insulin responsive cells.
1
Funding Rounds
$5.9m
Money raised
Celdara Medical is a biotechnology company helping turn academic innovations into medical products.
1
Funding Rounds
$1.7m
Money raised
Eureka Therapeutics is a biotechnology company developing immunotherapies for the treatment of cancer.
2
Funding Rounds
$105.0m
Money raised
Kiadis Pharma is a biotechnology company developing stem cell regenerative medicine treatments for blood cancers and blood disorders.
1
Funding Rounds
$12.8m
Money raised
Novadip Biosciences is a biotechnology company developing regenerative medicines using stem cells.
2
Funding Rounds
$82.0m
Money raised
GentiBio, Inc. is a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology.
2
Funding Rounds
$177.0m
Money raised
Gadeta is a biotechnology company developing immunotherapies for treating cancer.
1
Funding Rounds
$7.0m
Money raised
Kyverna is a cell therapy company engineering a new class of curative living medicines for inflammatory and autoimmune diseases.
2
Funding Rounds
$110.0m
Money raised
Ossium is building the world's first bone marrow bank to treat blood cancers, improve organ transplantation, and repair damage
3
Funding Rounds
$73.4m
Money raised
Immusoft is a biotechnology company developing a platform for the insertion of therapeutic genes into immune cells for the treatment of a variety of genetic diseases.
11
Funding Rounds
$37.9m
Money raised
Locate Bio is a biotechnology developing cell and gene therapies for treating damaged tissues and organs.
9
Funding Rounds
$59.1m
Money raised
Trailhead Biosystems is a biotechnology company developing cell therapy products.
3
Funding Rounds
$17.2m
Money raised
A Canadian biotechnology company that develops specialty cell culture media, cell isolation systems and accessory products for life science research.
1
Funding Rounds
$15.0m
Money raised
Abcuro develops immunotherapies to treat autoimmunity and cancer.
4
Funding Rounds
$72.3m
Money raised
Carisma Therapeutics is a biotechnology company founded in 2016 to bring the potheyr of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA).
2
Funding Rounds
$112.0m
Money raised
Refuge Biotechnologies is a biotechnology company that uses CRISPR and cell therapy technologies for treating cancer.
2
Funding Rounds
$33.9m
Money raised
AGT is developing and commercializing gene and cell therapy and targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma.
4
Funding Rounds
$6.0m
Money raised
A2 Biotherapeutics, Inc. is a biotechnology research company developing T-cell therapies designed to attack solid tumors while sparing normal cells
1
Funding Rounds
$71.5m
Money raised
TeVido Biodevices is a biotechnology company developing cell therapy products for restoring lost skin pigment.
4
Funding Rounds
$1.4m
Money raised
PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.
3
Funding Rounds
$200.0m
Money raised
StemBioSys is a biotechnology company developing regenerative medicines using stem cells.
1
Funding Rounds
$1.5m
Money raised
Mogrify is developing tailored cellular conversions that power future cell therapies.
8
Funding Rounds
$84.5m
Money raised
Biosceptre is a Cambridge, Cambridgeshire-based company developing diagnostic tools and biomarkers.
3
Funding Rounds
$13.2m
Money raised
Tactiva Therapeutics is a biotechnology company developing cancer immunotherapies.
1
Funding Rounds
$35.0m
Money raised
Stemedica Cell Technologies is a biopharmaceutical company developing and manufacturing adult stem cells and stem cell factors for research institutions and hospitals for pre-clinical and clinical studies
1
Funding Rounds
$22.0m
Money raised
Encoded Therapeutics is a developer of genomics-driven precision medicine targeting and treating genetic diseases and disorders.
4
Funding Rounds
$343.1m
Money raised
Cytonus Therapeutics is a biotechnology company developing adaptive cellular therapies for treating immune-oncology and inflammatory diseases.
4
Funding Rounds
$2.6m
Money raised
Universal Cells is a biotechnology company developing regenerative medicine using stem cells.
1
Funding Rounds
$60.0k
Money raised
Qihan Biotech is a hangzhou-based biotech company focused on organ transplantation founded in 2017 by Luhan Yang.
1
Funding Rounds
$67.0m
Money raised
Anagenesis Biotechnologies is a biotechnology company developing pre-clinical stem cell therapies for treating genetic and age-related muscle degenerative diseases.
1
Funding Rounds
$3.4m
Money raised
Targazyme is a biotechnology company focused on improving survival and quality of life for cancer patients using stem cell transplantation, immunotherapy, regenerative medicine, and gene therapy.
1
Funding Rounds
$2.5m
Money raised
Asklepios Biopharmaceutical is a company in North Carolina.
4
Funding Rounds
$241.9m
Money raised
TILT Biotherapeutics is a biotechnology company developing t-cell therapies using onolytic viruses for treating cancer.
2
Funding Rounds
$22.0m
Money raised
Taiga Biotechnologies is a biotechnology company developing blood stem cell therapies for treating infectious diseases and cancer.
1
Funding Rounds
$40.0m
Money raised
Cellares is a biotechnology and cell therapy company founded in 2019 by Fabian Gerlinghaus, Alex Pesch, and Omar Kurdi.
1
Funding Rounds
$82.0m
Money raised
NewLink Genetics is a biopharmaceutical company focused on the discovery and development of immuno-oncology products.
4
Funding Rounds
$37.4m
Money raised
Cell analysis technology provider.
4
Funding Rounds
$18.4m
Money raised
Elixirgen Therapeutics is a Baltimore-based biotechnology company.
3
Funding Rounds
$13.9m
Money raised
Vineti is a cloud-based cell-therapy management system founded in 2016 by Razmik Abnous.
6
Funding Rounds
$152.3m
Money raised
Unum Therapeutics is a biotechnology company developing cell therapy products for cancer immunotherapy applications.
1
Funding Rounds
$104.4m
Money raised
Convalesce is a company developing a stem cell based therapy for neurological conditions that leads to degeneration of neurons, like Parkinson's.
1
Funding Rounds
$250.0k
Money raised
Semma Therapeutics is a biotechnology company making regenerative medicine therapies using stem cells.
2
Funding Rounds
$114.0m
Money raised
Kytopen is a mircrofluidics company founded in 2017 by Paulo Garcia.
9
Funding Rounds
$42.4m
Money raised
Triumvira Immunologics is an adoptive Immunotherapy founded by Jonathan Bramson.
3
Funding Rounds
$171.2m
Money raised
Medeor Therapeutics is a biotechnology company developing personalized cellular immunotherapies to improve health outcomes of patients receiving organ transplants.
1
Funding Rounds
$57.0m
Money raised
WindMIL Therapeutics is a biotechnology company developing cell therapy products for treating cancer.
1
Funding Rounds
$5.0m
Money raised
Aruna Biomedical, Inc. is a stem Cell Research Products founded in 2003 by Tracey Worthington-Stice.
14
Funding Rounds
$73.9m
Money raised
Cellino (also known as Cellino Biotech) is a Cambridge, MA-based biotechnology company.
6
Funding Rounds
$93.1m
Money raised
Aspen Neuroscience develops autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS disorders.
3
Funding Rounds
$224.0m
Money raised
Personalized Stem Cells is a biotechnology company developing stem cell therapies for treating osteoarthritis, tendon/ligament injuries, and back pain.
2
Funding Rounds
$5.5m
Money raised
RepliCel Life Sciences is a biotechnology company developing regenerative medicines primarily using autologous cell therapy.
1
Funding Rounds
$594.1k
Money raised
Minerva Biotechnologies is a clinical-stage biopharmaceutical company focused on developing immunotherapies for solid tumor cancers and cellular therapies for regenerative medicine.
8
Funding Rounds
$113.7m
Money raised